4//SEC Filing
Mattessich Antony C. 4
Accession 0000950170-25-087889
CIK 0001501796other
Filed
Jun 17, 8:00 PM ET
Accepted
Jun 18, 4:10 PM ET
Size
20.2 KB
Accession
0000950170-25-087889
Insider Transaction Report
Form 4
Mattessich Antony C.
Director
Transactions
- Award
Common Stock
2025-06-17+13,000→ 23,500 total - Award
Stock Option (Right to Buy)
2025-06-17+17,000→ 17,000 totalExercise: $6.18Exp: 2035-06-17→ Common Stock (17,000 underlying)
Footnotes (2)
- [F1]These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in full upon the earlier to occur of (a) June 17, 2026 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date.
- [F2]This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 17, 2026 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date.
Documents
Issuer
Aura Biosciences, Inc.
CIK 0001501796
Entity typeother
Related Parties
1- filerCIK 0001709900
Filing Metadata
- Form type
- 4
- Filed
- Jun 17, 8:00 PM ET
- Accepted
- Jun 18, 4:10 PM ET
- Size
- 20.2 KB